On the public citation graph

Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity

https://doi.org/10.1021/acs.nanolett.0c02278
0 signed · 365 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/adma.201802233openalex-snapshot
T‐Cell‐Mimicking Nanoparticles Can Neutralize HIV Infectivity
inferredcites →https://doi.org/10.1016/j.bbrc.2020.03.044openalex-snapshot
Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses
inferredcites →https://doi.org/10.1016/j.ijid.2020.03.004openalex-snapshot
The SARS-CoV-2 outbreak: What we know
inferredcites →https://doi.org/10.1016/j.jinf.2020.03.037openalex-snapshot
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
inferredcites →https://doi.org/10.1016/s0140-6736(20)31022-9openalex-snapshot
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
inferredcites →https://doi.org/10.1016/s1441-2772(23)00387-3openalex-snapshot
Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy
inferredcites →https://doi.org/10.1038/d41586-020-01315-7openalex-snapshot
Profile of a killer: the complex biology powering the coronavirus pandemic
inferredcites →https://doi.org/10.1038/nrd.2015.37openalex-snapshot
Coronaviruses — drug discovery and therapeutic options
inferredcites →https://doi.org/10.1038/s41392-020-0191-1openalex-snapshot
Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2
inferredcites →https://doi.org/10.1038/s41577-020-0311-8openalex-snapshot
The trinity of COVID-19: immunity, inflammation and intervention
inferredcites →https://doi.org/10.1038/s41577-020-0331-4openalex-snapshot
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
inferredcites →https://doi.org/10.1039/c3nr06371bopenalex-snapshot
Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles
inferredcites →https://doi.org/10.1056/nejmp2000929openalex-snapshot
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment
inferredcites →https://doi.org/10.1073/pnas.1714267114openalex-snapshot
Macrophage-like nanoparticles concurrently absorbing endotoxins and proinflammatory cytokines for sepsis management
inferredcites →https://doi.org/10.1111/ijcp.13525openalex-snapshot
SARS‐CoV‐2 viral spike G614 mutation exhibits higher case fatality rate
inferredcites →https://doi.org/10.1126/science.aaa3778openalex-snapshot
Combating emerging viral threats
inferredcites →https://doi.org/10.1126/science.abb2762openalex-snapshot
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
inferredcites →https://doi.org/10.1182/blood.2020006000openalex-snapshot
COVID-19 and its implications for thrombosis and anticoagulation
inferredcites →https://doi.org/10.1681/asn.2020030276openalex-snapshot
Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia
inferredcites →https://doi.org/10.3201/eid2606.200516openalex-snapshot
Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3911094openalex-extracted
Therapeutic Effect of Macrophage-Derived Biomimetic Nanoparticles for Cytokine Release Syndrome
inferred← citeshttps://doi.org/10.2139/ssrn.4119293openalex-extracted
A Cell Membrane and V2c Mxene-Based Electrochemical Immunosensor with Enhanced Antifouling Capability for Detection of Cd44
inferred← citeshttps://doi.org/10.1002/9781394200559.ch15openalex-snapshot
Nanomaterials of Polymeric Design for the Treatment of Infectious Diseases
inferred← citeshttps://doi.org/10.1002/adfm.202008352openalex-snapshot
Biomimetic Nanomaterial Strategies for Virus Targeting: Antiviral Therapies and Vaccines
inferred← citeshttps://doi.org/10.1002/adfm.202100088openalex-snapshot
Cell‐Based Delivery Systems: Emerging Carriers for Immunotherapy
inferred← citeshttps://doi.org/10.1002/adhm.202101349openalex-snapshot
White Blood Cell Membrane‐Coated Nanoparticles: Recent Development and Medical Applications
inferred← citeshttps://doi.org/10.1002/adhm.202200283openalex-snapshot
Long‐Acting Protective Ocular Surface by Instilling Adhesive Dual‐Antiviral Nanoparticles
inferred← citeshttps://doi.org/10.1002/adhm.202400303openalex-snapshot
Macrophage‐Derived Nanosponges Adsorb Cytokines and Modulate Macrophage Polarization for Renal Cell Carcinoma Immunotherapy
inferred← citeshttps://doi.org/10.1002/adhm.202402103openalex-snapshot
Extracellular Vesicle‐Inspired Therapeutic Strategies for the COVID‐19
inferred← citeshttps://doi.org/10.1002/adhm.202402744openalex-snapshot
Protein Nanoparticles for Targeted SARS‐CoV‐2 Trapping and Neutralization
inferred← citeshttps://doi.org/10.1002/adma.202005424openalex-snapshot
Recent Progress on Biomaterials Fighting against Viruses
inferred← citeshttps://doi.org/10.1002/adma.202103471openalex-snapshot
Engineering Extracellular Vesicles Enriched with Palmitoylated ACE2 as COVID‐19 Therapy
inferred← citeshttps://doi.org/10.1002/adma.202107177openalex-snapshot
Biomembrane‐Functionalized Micromotors: Biocompatible Active Devices for Diverse Biomedical Applications
inferred← citeshttps://doi.org/10.1002/adma.202107719openalex-snapshot
Cellular Nanosponges for Biological Neutralization
inferred← citeshttps://doi.org/10.1002/adma.202207875openalex-snapshot
Vesicular Antibodies: Shedding Light on Antibody Therapeutics with Cell Membrane Nanotechnology
inferred← citeshttps://doi.org/10.1002/adma.202408294openalex-snapshot
Supramolecular Architectures of Dendritic Polymers Provide Irreversible Inhibitor to Block Viral Infection
inferred← citeshttps://doi.org/10.1002/adma.202505187openalex-snapshot
Natural Cell‐Inspired Nanoparticles: Preparation, Mechanisms, Applications, and Prospects for Clinical Translation
inferred← citeshttps://doi.org/10.1002/adtp.202100087openalex-snapshot
Discovery of Small Anti‐ACE2 Peptides to Inhibit SARS‐CoV‐2 Infectivity
inferred← citeshttps://doi.org/10.1002/advs.202100460openalex-snapshot
Genetically Engineered Cellular Membrane Vesicles as Tailorable Shells for Therapeutics
inferred← citeshttps://doi.org/10.1002/advs.202102330openalex-snapshot
Engineered Cell Membrane‐Derived Nanoparticles in Immune Modulation
inferred← citeshttps://doi.org/10.1002/advs.202103240openalex-snapshot
A Multifunctional Neutralizing Antibody‐Conjugated Nanoparticle Inhibits and Inactivates SARS‐CoV‐2
inferred← citeshttps://doi.org/10.1002/advs.202104495openalex-snapshot
Severe Acute Respiratory Syndrome Type 2‐Causing Coronavirus: Variants and Preventive Strategies
inferred← citeshttps://doi.org/10.1002/advs.202207098openalex-snapshot
Anti‐Coronaviral Nanocluster Restrain Infections of SARS‐CoV‐2 and Associated Mutants through Virucidal Inhibition and 3CL Protease Inactivation
inferred← citeshttps://doi.org/10.1002/advs.202401423openalex-snapshot
Macrophage‐Mimicking Cellular Nanoparticles Scavenge Proinflammatory Cytokines in Specimens of Patients with Inflammatory Disorders
inferred← citeshttps://doi.org/10.1002/advs.77592openalex-snapshot
Intelligent Programmable Membrane Nanosponge for Early Virus Blocking
inferred← citeshttps://doi.org/10.1002/anbr.202200010openalex-snapshot
Perspectives on the Technological Aspects and Biomedical Applications of Virus‐Like Particles/Nanoparticles in Reproductive Biology: Insights on the Medicinal and Toxicological Outlook
inferred← citeshttps://doi.org/10.1002/btm2.10441openalex-snapshot
Biomimetic cell membrane‐coated poly(lactic‐ co ‐glycolic acid) nanoparticles for biomedical applications
inferred← citeshttps://doi.org/10.1002/chem.202200947openalex-snapshot
Correct Identification of the Core‐Shell Structure of Cell Membrane‐Coated Polymeric Nanoparticles
inferred← citeshttps://doi.org/10.1002/cjoc.202100946openalex-snapshot
Construction of Nanocarriers Based on Endogenous Cell Membrane and Their Application in Nanomedicine
inferred← citeshttps://doi.org/10.1002/exp.20210157openalex-snapshot
Recent applications of immunomodulatory biomaterials for disease immunotherapy
inferred← citeshttps://doi.org/10.1002/exp.20220012openalex-snapshot
Keeping up with the COVID's—Could siRNA‐based antivirals be a part of the answer?
inferred← citeshttps://doi.org/10.1002/hsr2.1377openalex-snapshot
An update on vaccine status and the role of nanomedicine against SARS‐CoV‐2: A narrative review
inferred← citeshttps://doi.org/10.1002/jcp.30054openalex-snapshot
Single‐cell RNA sequencing analysis of SARS‐CoV‐2 entry receptors in human organoids
inferred← citeshttps://doi.org/10.1002/med.21997openalex-snapshot
COVID‐19 cooling: Nanostrategies targeting cytokine storm for controlling severe and critical symptoms
inferred← citeshttps://doi.org/10.1002/prp2.691openalex-snapshot
Therapeutic approaches against coronaviruses acute respiratory syndrome
inferred← citeshttps://doi.org/10.1002/slct.202302608openalex-snapshot
Giant Plasma Membrane Vesicles as Cellular‐Mimics for Probing SARS‐CoV‐2 Binding at Single Particle Level
inferred← citeshttps://doi.org/10.1002/smll.202101483openalex-snapshot
Graphene Oxide Nanosheets Interact and Interfere with SARS‐CoV‐2 Surface Proteins and Cell Receptors to Inhibit Infectivity
inferred← citeshttps://doi.org/10.1002/smll.202104402openalex-snapshot
Biomimetic Nanoparticles Enabled by Cascade Cell Membrane Coating for Direct Cross‐Priming of T Cells
inferred← citeshttps://doi.org/10.1002/smll.202305551openalex-snapshot
Extending the In Vivo Residence Time of Macrophage Membrane‐Coated Nanoparticles through Genetic Modification
inferred← citeshttps://doi.org/10.1002/smll.202305659openalex-snapshot
Engineered Macrophage Membrane‐Coated Nanoparticles with Enhanced CCR2 Expression Promote Spinal Cord Injury Repair by Suppressing Neuroinflammation and Neuronal death
inferred← citeshttps://doi.org/10.1002/smll.202310876openalex-snapshot
Surface Bio‐engineered Polymeric Nanoparticles
inferred← citeshttps://doi.org/10.1002/smll.202402146openalex-snapshot
Targeted Modulation of Redox and Immune Homeostasis in Acute Lung Injury Using a Thioether‐Functionalized Dendrimer
inferred← citeshttps://doi.org/10.1002/smmd.20230046openalex-snapshot
Pathogen‐binding nanoparticles to inhibit host cell infection by heparan sulfate and sialic acid dependent viruses and protozoan parasites
inferred← citeshttps://doi.org/10.1002/smtd.202300034openalex-snapshot
Nanotechnologies for the Diagnosis and Treatment of SARS‐CoV‐2 and Its Variants
inferred← citeshttps://doi.org/10.1002/smtd.202301178openalex-snapshot
Macrophage‐Biomimetic Nanoplatform‐Based Therapy for Inflammation‐Associated Diseases
inferred← citeshttps://doi.org/10.1002/sstr.202000018openalex-snapshot
Drug Targeting via Platelet Membrane–Coated Nanoparticles
inferred← citeshttps://doi.org/10.1002/sstr.202200021openalex-snapshot
New Advances in Nanomaterial‐Based Antiviral Strategies
inferred← citeshttps://doi.org/10.1002/sstr.202300473openalex-snapshot
Hybrid Cell Membrane‐Coated Nanoparticles for Biomedical Applications
inferred← citeshttps://doi.org/10.1002/viw.20200105openalex-snapshot
Potential nanoparticle applications for prevention, diagnosis, and treatment of COVID‐19
inferred← citeshttps://doi.org/10.1002/viw.20200180openalex-snapshot
Advances of nanomaterials‐based strategies for fighting against COVID‐19
inferred← citeshttps://doi.org/10.1002/viw.20200181openalex-snapshot
Detection, prevention and treatment of COVID‐19 and opportunities for nanobiotechnology
inferred← citeshttps://doi.org/10.1002/viw.20200186openalex-snapshot
Exosome therapeutics for COVID‐19 and respiratory viruses
inferred← citeshttps://doi.org/10.1002/wnan.1707openalex-snapshot
Silver nanoparticles as a potential treatment against SARS‐CoV ‐2: A review
inferred← citeshttps://doi.org/10.1007/978-1-0716-2716-7_3openalex-snapshot
Nanotechnology-Driven Delivery Systems in Inoculation Therapies
inferred← citeshttps://doi.org/10.1007/978-3-030-65792-5_14openalex-snapshot
Nanoparticles-Mediated Interventions to Prevent Herpes Simplex Virus (HSV) Entry into Susceptible Hosts
inferred← citeshttps://doi.org/10.1007/978-3-031-41077-2_4openalex-snapshot
Characterization Techniques for Nanosponges
inferred← citeshttps://doi.org/10.1007/978-981-16-9190-4_2openalex-snapshot
Application of Nanotechnology in the Treatment of Infectious Diseases: An Overview
inferred← citeshttps://doi.org/10.1007/978-981-33-6300-7_6openalex-snapshot
Potential Therapeutic Approaches for SARS CoV2 Infection
inferred← citeshttps://doi.org/10.1007/978-981-97-7292-6_23openalex-snapshot
Nanotheronostics: Part II
inferred← citeshttps://doi.org/10.1007/978-981-99-6564-9_1openalex-snapshot
Biological Methods for Drug Delivery
inferred← citeshttps://doi.org/10.1007/s10529-021-03209-8openalex-snapshot
Stem cells or their exosomes: which is preferred in COVID-19 treatment?
inferred← citeshttps://doi.org/10.1007/s11051-020-05010-6openalex-snapshot
Pharmaceutical nanotechnology: which products are been designed against COVID-19?
inferred← citeshttps://doi.org/10.1007/s11051-022-05396-5openalex-snapshot
Polymeric nanoparticles as therapeutic agents against coronavirus disease
inferred← citeshttps://doi.org/10.1007/s11051-022-05452-0openalex-snapshot
Nanotechnology and COVID-19: quo vadis?
inferred← citeshttps://doi.org/10.1007/s11051-023-05867-3openalex-snapshot
Potential and risks of nanotechnology applications in COVID-19-related strategies for pandemic control
inferred← citeshttps://doi.org/10.1007/s11244-025-02249-yopenalex-snapshot
A Review on Nanomaterials Based Antiviral Strategies Targeting SARS CoV-2 Replication and Infection Mechanisms
inferred← citeshttps://doi.org/10.1007/s11696-023-02795-3openalex-snapshot
Superior possibilities and upcoming horizons for nanoscience in COVID-19: noteworthy approach for effective diagnostics and management of SARS-CoV-2 outbreak
inferred← citeshttps://doi.org/10.1007/s11696-023-03271-8openalex-snapshot
Overview of diagnostic tools and nano-based therapy of SARS-CoV-2 infection
inferred← citeshttps://doi.org/10.1007/s11696-026-04896-1openalex-snapshot
Nanosponges as biomimetic decoy platforms for broad-spectrum toxin sequestration and targeted detoxification: from materials design to clinical translation
inferred← citeshttps://doi.org/10.1007/s12011-023-03788-9openalex-snapshot
The Possible Mechanisms of Cu and Zn in the Treatment and Prevention of HIV and COVID-19 Viral Infection
inferred← citeshttps://doi.org/10.1007/s12274-021-3949-zopenalex-snapshot
Nanoagent-based theranostic strategies against human coronaviruses
inferred← citeshttps://doi.org/10.1007/s12668-022-01000-1openalex-snapshot
Versatile Applications of Nanosponges in Biomedical Field: A Glimpse on SARS-CoV-2 Management
inferred← citeshttps://doi.org/10.1007/s13204-021-01900-wopenalex-snapshot
SARS-CoV-2 and its new variants: a comprehensive review on nanotechnological application insights into potential approaches
inferred← citeshttps://doi.org/10.1007/s13205-020-02619-1openalex-snapshot
Recent biotechnological advances as potential intervention strategies against COVID-19
inferred← citeshttps://doi.org/10.1007/s13346-021-00965-yopenalex-snapshot
Nanotechnology advances in pathogen- and host-targeted antiviral delivery: multipronged therapeutic intervention for pandemic control
inferred← citeshttps://doi.org/10.1007/s13346-023-01494-6openalex-snapshot
Cell-derived biomimetic nanoparticles for the targeted therapy of ALI/ARDS
inferred← citeshttps://doi.org/10.1007/s40242-025-5042-8openalex-snapshot
Production of PLGA Nanoparticles via Nanoprecipitation: A Systemic Study on Synthesis Conditions
inferred← citeshttps://doi.org/10.1007/s40820-021-00598-3openalex-snapshot
Nanoplatforms for Sepsis Management: Rapid Detection/Warning, Pathogen Elimination and Restoring Immune Homeostasis
inferred← citeshttps://doi.org/10.1007/s42247-020-00143-9openalex-snapshot
An overview of the use of biomaterials, nanotechnology, and stem cells for detection and treatment of COVID-19: towards a framework to address future global pandemics
inferred← citeshttps://doi.org/10.1007/s42247-021-00171-zopenalex-snapshot
Harnessing biomaterials for therapeutic strategies against COVID-19
inferred← citeshttps://doi.org/10.1007/s42247-021-00179-5openalex-snapshot
Recent advances in materials science: a reinforced approach toward challenges against COVID-19
inferred← citeshttps://doi.org/10.1007/s42247-021-00182-wopenalex-snapshot
New insights into application of nanoparticles in the diagnosis and screening of novel coronavirus (SARS-CoV-2)
inferred← citeshttps://doi.org/10.1007/s44174-023-00077-wopenalex-snapshot
Organic–Inorganic Hybrid Nanocomposites for Nanotheranostics: Special Focus on Preventing Emerging Variants of SARS-COV-2
inferred← citeshttps://doi.org/10.1007/s44178-026-00296-3openalex-snapshot
Advances and projects of immunomodulatory biomaterials used for immunotherapy
inferred← citeshttps://doi.org/10.1016/b978-0-12-822425-0.00020-8openalex-snapshot
Cell membrane-coated nanoparticles and their biomedical applications
inferred← citeshttps://doi.org/10.1016/b978-0-12-823915-5.00014-9openalex-snapshot
Bionanomaterials for diagnosis and therapy of SARS-CoV-2
inferred← citeshttps://doi.org/10.1016/b978-0-323-88450-1.00024-7openalex-snapshot
Clinical potential of nanotechnlogy as smart therapeutics: A step toward targeted drug delivery
inferred← citeshttps://doi.org/10.1016/b978-0-323-89972-7.00011-8openalex-snapshot
Current strategies and future perspectives in COVID-19 therapy
inferred← citeshttps://doi.org/10.1016/b978-0-323-90248-9.00012-7openalex-snapshot
Antivirals based on nanomaterials against SARS-CoV-2
inferred← citeshttps://doi.org/10.1016/b978-0-323-91201-3.00007-4openalex-snapshot
Polymeric nanomaterials for infectious diseases
inferred← citeshttps://doi.org/10.1016/b978-0-323-91684-4.00004-9openalex-snapshot
Current applications of biomolecules as anticoronavirus drugs
inferred← citeshttps://doi.org/10.1016/b978-0-323-91814-5.00001-5openalex-snapshot
Nanovesicles for delivery of antiviral agents
inferred← citeshttps://doi.org/10.1016/b978-0-323-91814-5.00002-7openalex-snapshot
Antiviral biomaterials
inferred← citeshttps://doi.org/10.1016/b978-0-323-99148-3.00012-1openalex-snapshot
Role of nanocomposites for the prevention and treatment of viral infections in the health care system
inferred← citeshttps://doi.org/10.1016/b978-0-443-33002-5.00005-1openalex-snapshot
Nanomaterial-based therapeutic drugs for SARS-CoV-2 variants: Recent findings, limitations, and prospects
inferred← citeshttps://doi.org/10.1016/b978-0-443-33002-5.00015-4openalex-snapshot
Nanotechnological approaches for COVID-19 management: Highlighting the impact on SARS-Co-V-2 variants
inferred← citeshttps://doi.org/10.1016/b978-0-443-33002-5.00023-3openalex-snapshot
COVID-19 drug delivery: Current achievements and the impact of nanocarriers
inferred← citeshttps://doi.org/10.1016/b978-0-443-33643-0.00003-xopenalex-snapshot
Assessment of environmental sustainability
inferred← citeshttps://doi.org/10.1016/b978-0-443-33871-7.00012-xopenalex-snapshot
Pandemics of tomorrow: how AI and nanotech will transform global health
inferred← citeshttps://doi.org/10.1016/j.abst.2020.08.001openalex-snapshot
Biomarkers of COVID-19 and technologies to combat SARS-CoV-2
inferred← citeshttps://doi.org/10.1016/j.addr.2020.12.011openalex-snapshot
COVID-19 vaccines: The status and perspectives in delivery points of view
inferred← citeshttps://doi.org/10.1016/j.addr.2021.01.002openalex-snapshot
Nanocarrier vaccines for SARS-CoV-2
inferred← citeshttps://doi.org/10.1016/j.addr.2021.114006openalex-snapshot
Engineering of stimuli-responsive self-assembled biomimetic nanoparticles
inferred← citeshttps://doi.org/10.1016/j.addr.2023.115111openalex-snapshot
Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy
inferred← citeshttps://doi.org/10.1016/j.addr.2024.115320openalex-snapshot
Cell membrane-coated nanoparticles for targeting carcinogenic bacteria
inferred← citeshttps://doi.org/10.1016/j.antiviral.2026.106482openalex-snapshot
Nanoparticles in viral pneumonia: diagnosis, therapy, and prevention
inferred← citeshttps://doi.org/10.1016/j.apsb.2021.04.023openalex-snapshot
Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design
inferred← citeshttps://doi.org/10.1016/j.apsb.2021.09.004openalex-snapshot
Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles
inferred← citeshttps://doi.org/10.1016/j.apsb.2021.09.025openalex-snapshot
Bioinspired membrane-based nanomodulators for immunotherapy of autoimmune and infectious diseases
inferred← citeshttps://doi.org/10.1016/j.apsb.2022.01.019openalex-snapshot
Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants
inferred← citeshttps://doi.org/10.1016/j.apsb.2022.08.020openalex-snapshot
Cellular nanovesicles for therapeutic immunomodulation: A perspective on engineering strategies and new advances
inferred← citeshttps://doi.org/10.1016/j.apsb.2022.09.011openalex-snapshot
Localized delivery of nanomedicine and antibodies for combating COVID-19
inferred← citeshttps://doi.org/10.1016/j.apsb.2023.02.010openalex-snapshot
Regulating the microenvironment with nanomaterials: Potential strategies to ameliorate COVID-19
inferred← citeshttps://doi.org/10.1016/j.bioactmat.2025.05.030openalex-snapshot
Antiviral nanomedicine: Advantages, mechanisms and advanced therapies
inferred← citeshttps://doi.org/10.1016/j.bioactmat.2025.07.028openalex-snapshot
Advanced nanotherapies for precision treatment of inflammatory lung diseases
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2021.120824openalex-snapshot
Sponge particulates for biomedical applications: Biofunctionalization, multi-drug shielding, and theranostic applications
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2023.122330openalex-snapshot
Glycan-modified cellular nanosponges for enhanced neutralization of botulinum toxin
inferred← citeshttps://doi.org/10.1016/j.bsheal.2022.06.001openalex-snapshot
Advances in nanotechnology application in biosafety materials: A crucial response to COVID-19 pandemic
inferred← citeshttps://doi.org/10.1016/j.carbpol.2022.119500openalex-snapshot
Chitosan and its derivatives as polymeric anti-viral therapeutics and potential anti-SARS-CoV-2 nanomedicine
inferred← citeshttps://doi.org/10.1016/j.cclet.2021.03.015openalex-snapshot
Challenges in cell membrane-camouflaged drug delivery systems: Development strategies and future prospects
inferred← citeshttps://doi.org/10.1016/j.cej.2023.143844openalex-snapshot
GlycoEVLR: Glycosylated extracellular vesicle-like receptors for targeting and sensing viral antigen
inferred← citeshttps://doi.org/10.1016/j.cej.2024.157285openalex-snapshot
Macrophage membrane-mediated targeted curcumin biomimetic nanoparticles delivery for diagnosis and treatment of spinal cord injury by suppressing neuroinflammation and ferroptosis
inferred← citeshttps://doi.org/10.1016/j.cej.2026.176905openalex-snapshot
Human GBP1-neobaicalein targeted bacteria biomimetic nanodelivery system for dual inhibition of host efflux pumps and bacterial outer membrane to eliminate carbapenem-resistant gram-negative bacteria
inferred← citeshttps://doi.org/10.1016/j.celbio.2025.100017openalex-snapshot
Antiviral covalent ACE2 vesicle spray
inferred← citeshttps://doi.org/10.1016/j.cell.2021.03.027openalex-snapshot
SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms
inferred← citeshttps://doi.org/10.1016/j.cis.2025.103761openalex-snapshot
The surface-first paradigm: Engineering nanocarriers for infection-responsive drug delivery
inferred← citeshttps://doi.org/10.1016/j.cobme.2021.100363openalex-snapshot
Antibacterial and antiviral high-performance nanosystems to mitigate new SARS-CoV-2 variants of concern
inferred← citeshttps://doi.org/10.1016/j.colcom.2020.100356openalex-snapshot
Spectroscopic investigation on the affinity of SARS-CoV-2 spike protein to gold nano-particles
inferred← citeshttps://doi.org/10.1016/j.colsurfa.2021.126275openalex-snapshot
Nano-size dependence in the adsorption by the SARS-CoV-2 spike protein over gold colloid
inferred← citeshttps://doi.org/10.1016/j.colsurfb.2023.113731openalex-snapshot
Magnetically controlled nanorobots induced oriented and rapid clearance of the cytokine storm for acute lung injury therapy
inferred← citeshttps://doi.org/10.1016/j.colsurfb.2024.113893openalex-snapshot
Biomembrane camouflaged nanoparticles: A paradigm shifts in targeted drug delivery system
inferred← citeshttps://doi.org/10.1016/j.cossms.2021.100964openalex-snapshot
Nanoparticle approaches against SARS-CoV-2 infection
inferred← citeshttps://doi.org/10.1016/j.drudis.2021.01.035openalex-snapshot
Bio-inspired nanomaterials as novel options for the treatment of cardiovascular disease
inferred← citeshttps://doi.org/10.1016/j.drudis.2022.07.015openalex-snapshot
Nanosponges: An overlooked promising strategy to combat SARS-CoV-2
inferred← citeshttps://doi.org/10.1016/j.ejpb.2022.05.018openalex-snapshot
Comparing extracellular vesicles and cell membranes as biocompatible coatings for gold nanorods: Implications for targeted theranostics
inferred← citeshttps://doi.org/10.1016/j.ejphar.2021.173930openalex-snapshot
COVID-19 infection and nanomedicine applications for development of vaccines and therapeutics: An overview and future perspectives based on polymersomes
inferred← citeshttps://doi.org/10.1016/j.heliyon.2021.e06841openalex-snapshot
The role of nanotechnology in current COVID-19 outbreak
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2022.121790openalex-snapshot
“Nanodecoys” - Future of drug delivery by encapsulating nanoparticles in natural cell membranes
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2025.126122openalex-snapshot
Recent progress in anti-atherosclerosis strategies and prospective therapeutic targets
inferred← citeshttps://doi.org/10.1016/j.jconrel.2020.08.060openalex-snapshot
Nanotheranostics against COVID-19: From multivalent to immune-targeted materials
inferred← citeshttps://doi.org/10.1016/j.jconrel.2021.08.046openalex-snapshot
Nano-engineered tools in the diagnosis, therapeutics, prevention, and mitigation of SARS-CoV-2
inferred← citeshttps://doi.org/10.1016/j.jconrel.2022.04.027openalex-snapshot
COVID-19 inflammation and implications in drug delivery
inferred← citeshttps://doi.org/10.1016/j.jconrel.2022.04.046openalex-snapshot
Engineered extracellular vesicles and their mimics in cardiovascular diseases
inferred← citeshttps://doi.org/10.1016/j.jconrel.2023.11.004openalex-snapshot
Nanomedicine approaches against SARS-CoV-2 and variants
inferred← citeshttps://doi.org/10.1016/j.jddst.2023.104567openalex-snapshot
Nano-based techniques: A revolutionary approach to prevent covid-19 and enhancing human awareness
inferred← citeshttps://doi.org/10.1016/j.jddst.2024.106009openalex-snapshot
Recent advances on the application of nanobiomimetic structures as drug delivery systems
inferred← citeshttps://doi.org/10.1016/j.jddst.2024.106258openalex-snapshot
Nanosponges in therapeutics: Current advancements and future directions in targeted drug delivery
inferred← citeshttps://doi.org/10.1016/j.jddst.2025.106960openalex-snapshot
Exploring natural components in vaccine delivery systems: Types, routes of administration, in-vitro and in-vivo quantification techniques
inferred← citeshttps://doi.org/10.1016/j.jgar.2021.05.021openalex-snapshot
Vaccine or monoclonal therapy: which is the winning weapon against COVID-19?
inferred← citeshttps://doi.org/10.1016/j.jhazmat.2022.129868openalex-snapshot
Exploring an ultra-sensitive electrochemiluminescence monitoring strategy for SARS-CoV-2 using hairpin-assisted cycling and dumbbell hybridization chain amplification
inferred← citeshttps://doi.org/10.1016/j.jre.2022.04.005openalex-snapshot
IFE based nanosensor composed of UCNPs and Fe(II)-phenanthroline for detection of hypochlorous acid and periodic acid
inferred← citeshttps://doi.org/10.1016/j.lfs.2020.118761openalex-snapshot
Nano-based approaches in the development of antiviral agents and vaccines
inferred← citeshttps://doi.org/10.1016/j.mam.2021.101007openalex-snapshot
Nanodelivery of STING agonists against cancer and infectious diseases
inferred← citeshttps://doi.org/10.1016/j.matt.2021.03.016openalex-snapshot
Antiviral biomaterials
inferred← citeshttps://doi.org/10.1016/j.matt.2021.04.005openalex-snapshot
Nanotraps for the containment and clearance of SARS-CoV-2
inferred← citeshttps://doi.org/10.1016/j.matt.2021.09.022openalex-snapshot
Inhaled ACE2-engineered microfluidic microsphere for intratracheal neutralization of COVID-19 and calming of the cytokine storm
inferred← citeshttps://doi.org/10.1016/j.matt.2022.11.027openalex-snapshot
Supramolecular filaments for concurrent ACE2 docking and enzymatic activity silencing enable coronavirus capture and infection prevention
inferred← citeshttps://doi.org/10.1016/j.mehy.2020.110245openalex-snapshot
SARS-CoV-2 and miRNA-like inhibition power
inferred← citeshttps://doi.org/10.1016/j.micpath.2023.106356openalex-snapshot
Antibiotics and nano-antibiotics in treatment of lung infection: In management of COVID-19
inferred← citeshttps://doi.org/10.1016/j.molliq.2022.119795openalex-snapshot
A systemic review on liquid crystals, nanoformulations and its application for detection and treatment of SARS – CoV- 2 (COVID – 19)
inferred← citeshttps://doi.org/10.1016/j.mtbio.2025.101716openalex-snapshot
Improving tumor treatment: Cell membrane-coated nanoparticles for targeted therapies
inferred← citeshttps://doi.org/10.1016/j.nantod.2020.101019openalex-snapshot
Insights from nanotechnology in COVID-19 treatment
inferred← citeshttps://doi.org/10.1016/j.nantod.2020.101031openalex-snapshot
Nanotechnology for virus treatment
inferred← citeshttps://doi.org/10.1016/j.nantod.2021.101267openalex-snapshot
Antiviral nanoparticles for sanitizing surfaces: A roadmap to self-sterilizing against COVID-19
inferred← citeshttps://doi.org/10.1016/j.nantod.2022.101580openalex-snapshot
Multivalent ACE2 engineering—A promising pathway for advanced coronavirus nanomedicine development
inferred← citeshttps://doi.org/10.1016/j.omtm.2021.03.003openalex-snapshot
In vitro characterization of engineered red blood cells as viral traps against HIV-1 and SARS-CoV-2
inferred← citeshttps://doi.org/10.1016/j.phrs.2023.107022openalex-snapshot
Macrophage-related therapeutic strategies: Regulation of phenotypic switching and construction of drug delivery systems
inferred← citeshttps://doi.org/10.1016/j.progpolymsci.2021.101410openalex-snapshot
Future antiviral polymers by plasma processing
inferred← citeshttps://doi.org/10.1016/j.reth.2024.03.015openalex-snapshot
Potential therapeutic effects and nano-based delivery systems of mesenchymal stem cells and their isolated exosomes to alleviate acute respiratory distress syndrome caused by COVID-19
inferred← citeshttps://doi.org/10.1016/j.scitotenv.2021.145989openalex-snapshot
Protection, disinfection, and immunization for healthcare during the COVID-19 pandemic: Role of natural and synthetic macromolecules
inferred← citeshttps://doi.org/10.1016/j.seppur.2025.133948openalex-snapshot
Continuous separation of cell membranes via affinity chromatography
inferred← citeshttps://doi.org/10.1021/acs.analchem.2c05464openalex-snapshot
Virus-like Plasmonic Nanoprobes for Quick Analysis of Antiviral Efficacy and Mutation-Induced Drug Resistance
inferred← citeshttps://doi.org/10.1021/acs.biomac.1c00440openalex-snapshot
Hybrid Membrane-Coated Biomimetic Nanoparticles (HM@BNPs): A Multifunctional Nanomaterial for Biomedical Applications
inferred← citeshttps://doi.org/10.1021/acs.iecr.2c01587openalex-snapshot
Cell Membrane-Coated Nanoparticles for Management of Infectious Diseases: A Review
inferred← citeshttps://doi.org/10.1021/acs.langmuir.0c00637openalex-snapshot
RBC-Derived Optical Nanoparticles Remain Stable After a Freeze–Thaw Cycle
inferred← citeshttps://doi.org/10.1021/acs.nanolett.1c04813openalex-snapshot
Nano Letters in the Time of COVID-19
inferred← citeshttps://doi.org/10.1021/acs.nanolett.2c03881openalex-snapshot
Single Low-Dose Nanovaccine for Long-Term Protection against Anthrax Toxins
inferred← citeshttps://doi.org/10.1021/acs.nanolett.3c01983openalex-snapshot
Cytoplasm Hydrogelation-Mediated Cardiomyocyte Sponge Alleviated Coxsackievirus B3 Infection
inferred← citeshttps://doi.org/10.1021/acs.nanolett.4c04653openalex-snapshot
Cellular Nanoparticles Treat Coronavirus Infection in Vivo
inferred← citeshttps://doi.org/10.1021/acsabm.0c01004openalex-snapshot
Electrochemical SARS-CoV-2 Sensing at Point-of-Care and Artificial Intelligence for Intelligent COVID-19 Management
inferred← citeshttps://doi.org/10.1021/acsabm.0c01072openalex-snapshot
Bacteria-Inspired Nanomedicine
inferred← citeshttps://doi.org/10.1021/acsabm.4c00074openalex-snapshot
T Cell and Natural Killer Cell Membrane-Camouflaged Nanoparticles for Cancer and Viral Therapies
inferred← citeshttps://doi.org/10.1021/acsami.1c19541openalex-snapshot
HACE2-Exosome-Based Nano-Bait for Concurrent SARS-CoV-2 Trapping and Antioxidant Therapy
inferred← citeshttps://doi.org/10.1021/acsami.4c07234openalex-snapshot
Cellular Output and Physicochemical Properties of the Membrane-Derived Vesicles Depend on Chemical Stimulants
inferred← citeshttps://doi.org/10.1021/acsami.5c03831openalex-snapshot
High-Lethality Precision-Guided Nanomissile for Broad-Spectrum Virucidal and Anti-Inflammatory Therapy
inferred← citeshttps://doi.org/10.1021/acsbiomaterials.0c01287openalex-snapshot
Biomaterials-Based Opportunities to Engineer the Pulmonary Host Immune Response in COVID-19
inferred← citeshttps://doi.org/10.1021/acsbiomaterials.3c00364openalex-snapshot
Tailoring the Inherent Properties of Biobased Nanoparticles for Nanomedicine
inferred← citeshttps://doi.org/10.1021/acscentsci.1c01368openalex-snapshot
Potent Virustatic Polymer–Lipid Nanomimics Block Viral Entry and Inhibit Malaria Parasites In Vivo
inferred← citeshttps://doi.org/10.1021/acsinfecdis.1c00331openalex-snapshot
The CARB-X Portfolio of Nontraditional Antibacterial Products
inferred← citeshttps://doi.org/10.1021/acsinfecdis.3c00528openalex-snapshot
Progress in Treatment and Diagnostics of Infectious Disease with Polymers
inferred← citeshttps://doi.org/10.1021/acsnano.0c06836openalex-snapshot
Membrane Nanoparticles Derived from ACE2-Rich Cells Block SARS-CoV-2 Infection
inferred← citeshttps://doi.org/10.1021/acsnano.1c00680openalex-snapshot
Targeted Noninvasive Treatment of Choroidal Neovascularization by Hybrid Cell-Membrane-Cloaked Biomimetic Nanoparticles
inferred← citeshttps://doi.org/10.1021/acsnano.1c03800openalex-snapshot
Cell Membrane-Coated Mimics: A Methodological Approach for Fabrication, Characterization for Therapeutic Applications, and Challenges for Clinical Translation
inferred← citeshttps://doi.org/10.1021/acsnano.2c08319openalex-snapshot
Neuronal Cellular Nanosponges for Effective Detoxification of Neurotoxins
inferred← citeshttps://doi.org/10.1021/acsnano.3c03959openalex-snapshot
Capsulated Cellular Nanosponges for the Treatment of Experimental Inflammatory Bowel Disease
inferred← citeshttps://doi.org/10.1021/acsnano.4c09830openalex-snapshot
Research Advances of Cellular Nanoparticles as Multiplex Countermeasures
inferred← citeshttps://doi.org/10.1021/acssensors.2c01215openalex-snapshot
Cell Membrane and V 2 C MXene-Based Electrochemical Immunosensor with Enhanced Antifouling Capability for Detection of CD44
inferred← citeshttps://doi.org/10.1021/bk-2022-1429.ch009openalex-snapshot
Investigation of Protein-Protein Interactions Utilizing a Nano-Gold Colloid Surface Plasmon Resonance: Application to SARS CoV-2 Spike Protein Coated Gold Colloids
inferred← citeshttps://doi.org/10.1021/jacs.1c07798openalex-snapshot
Surface Glycan Modification of Cellular Nanosponges to Promote SARS-CoV-2 Inhibition
inferred← citeshttps://doi.org/10.1038/s41368-021-00144-2openalex-snapshot
Fibroblast membrane-camouflaged nanoparticles for inflammation treatment in the early stage
showing the first 200 of 345
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.